T1	Participants 15 36	chronic heart failure
T2	Participants 358 399	two large populations of patients with HF
T3	Participants 496 655	1457 patients enrolled in the Controlled Rosuvastatin Multinational Trial in HF (CORONA) and 1233 patients enrolled in the GISSI-Heart Failure trial (GISSI-HF)
T4	Participants 1715 1739	patients with chronic HF
